Table 4.
n | Mean±SD (%) | Statistical significance | ||
FVC (%) baseline | Non-dropout | 14 | 67.64±10.40 | p=0.021 |
Dropout | 17 | 57.12±11.58 | ||
FVC (%) first year | Non-dropout | 11 | 76.00±18.39 | p=0.005 |
Dropout | 9 | 50.78±12.69 | ||
FVC (%) second year | Non-dropout | 6 | 76.00±12.44 | p=0.061 |
Dropout | 5 | 54.40±5.55 | ||
FVC (%) third year | Non-dropout | 3 | 86.33±16.44 | p=0.400 |
Dropout | 2 | 4800±11.31 |
Significance p<0.05 (95% CI). A dropout was a patient who discontinued pirfenidone at any time.
FVC, forced vital capacity.